标题
Breast cancer
作者
关键词
-
出版物
Nature Reviews Disease Primers
Volume 5, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-23
DOI
10.1038/s41572-019-0111-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer
- (2019) Camilla Wendt et al. ACTA ONCOLOGICA
- A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer
- (2019) Carol Forbes et al. Cancer Management and Research
- Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
- (2019) Shu-Lian Wang et al. LANCET ONCOLOGY
- Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Michael Gnant et al. LANCET ONCOLOGY
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials
- (2019) Richard Gray et al. LANCET
- Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
- (2019) Meran Keshawa Ediriweera et al. DRUG DISCOVERY TODAY
- Prognostic models for breast cancer: a systematic review
- (2019) Minh Tung Phung et al. BMC CANCER
- St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment
- (2019) Marija Balic et al. Breast Care
- Breast cancer risk of hormonal contraception: Counselling considering new evidence
- (2019) Lino Del Pup et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- “Between Uncertainties and Overtreatment”
- (2019) Orit Kaidar-Person et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer
- (2019) Ulrike Nitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Capivasertib (AZD5363) plus fulvestrant versus placebo plus fulvestrant after relapse or progression on an aromatase inhibitor in metastatic ER-positive breast cancer (FAKTION): A randomized, double-blind, placebo-controlled, phase II trial.
- (2019) Robert Hugh Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx).
- (2019) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.
- (2019) Cristina Saura et al. JOURNAL OF CLINICAL ONCOLOGY
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
- (2019) Helena M Earl et al. LANCET
- Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
- (2019) Kenji Tamura et al. LANCET ONCOLOGY
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
- (2018) G Curigliano et al. ANNALS OF ONCOLOGY
- Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
- (2018) Y Bareche et al. ANNALS OF ONCOLOGY
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Impact of Breast Surgery in Primary Metastasized Breast Cancer
- (2018) Florian Fitzal et al. ANNALS OF SURGERY
- Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015)
- (2018) JFR Robertson et al. CANCER RESEARCH
- Abstract GS1-01: Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials
- (2018) R Gray et al. CANCER RESEARCH
- Inflammatory breast cancer: The pathologists' perspective
- (2018) G. Cserni et al. EJSO
- Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort
- (2018) Elisa Gobbini et al. EUROPEAN JOURNAL OF CANCER
- Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study
- (2018) Marit Busund et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER.
- (2018) Jose Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis
- (2018) Mingming Liang et al. Molecular Diagnosis & Therapy
- Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2018) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial
- (2018) Patricia J.A.M. Brouwers et al. RADIOTHERAPY AND ONCOLOGY
- Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer
- (2018) David Krug et al. STRAHLENTHERAPIE UND ONKOLOGIE
- X chromosome gain is related to increased androgen receptor expression in male breast cancer
- (2018) Enrico Di Oto et al. VIRCHOWS ARCHIV
- Health-related quality of life in Asian patients with breast cancer: a systematic review
- (2018) Peh Joo Ho et al. BMJ Open
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2018) Heikki Joensuu et al. JAMA Oncology
- The impact of legislation mandating breast density notification – Review of the evidence
- (2018) Nehmat Houssami et al. BREAST
- Male breast cancer: a disease distinct from female breast cancer
- (2018) Ayca Gucalp et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.
- (2018) Peter Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study.
- (2018) Robert E. Coleman et al. JOURNAL OF CLINICAL ONCOLOGY
- HER kinase inhibition in patients with HER2- and HER3-mutant cancers
- (2018) David M. Hyman et al. NATURE
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis
- (2018) Kai Zhang et al. Cancer Management and Research
- 193OAn international update of the EORTC questionnaire for assessing quality of life in breast cancer patients (EORTC QLQ-BC23) - EORTC QLQ-BR45
- (2018) V Bjelic-Radisic et al. ANNALS OF ONCOLOGY
- LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
- (2018) F André et al. ANNALS OF ONCOLOGY
- Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
- (2018) Jin-Xiao Ren et al. BREAST CANCER RESEARCH AND TREATMENT
- Accelerated partial breast irradiation: Current status with a focus on clinical practice
- (2018) Fabiana A. Miranda et al. Breast Journal
- Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer
- (2018) Scott Klarenbach et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California
- (2018) Li Tao et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Breast cancer in transgender patients: A systematic review. Part 1: Male to female
- (2018) Rebecca L. Hartley et al. EJSO
- Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications
- (2018) Amy Ellen McCart Reed et al. JOURNAL OF PATHOLOGY
- Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial
- (2018) Galina Velikova et al. LANCET ONCOLOGY
- Current and future perspectives of liquid biopsies in genomics-driven oncology
- (2018) Ellen Heitzer et al. NATURE REVIEWS GENETICS
- Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
- (2018) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
- (2018) Yasmeen Razvi et al. SUPPORTIVE CARE IN CANCER
- A review of estrogen receptor/androgen receptor genomics in male breast cancer
- (2017) Tesa M Severson et al. ENDOCRINE-RELATED CANCER
- Primary metastatic breast cancer in the era of targeted therapy – Prognostic impact and the role of breast tumour surgery
- (2017) Jana Barinoff et al. EUROPEAN JOURNAL OF CANCER
- European Breast Cancer Conference manifesto on breast centres/units
- (2017) Fatima Cardoso et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer
- (2017) Xia Wang et al. GENES CHROMOSOMES & CANCER
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry
- (2017) Dieter Hölzel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
- (2017) Joanne L. Blum et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2017) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
- (2017) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial
- (2017) Akiko Hanai et al. JNCI-Journal of the National Cancer Institute
- The global burden of women’s cancers: a grand challenge in global health
- (2017) Ophira Ginsburg et al. LANCET
- Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) José Baselga et al. LANCET ONCOLOGY
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Miguel Martin et al. LANCET ONCOLOGY
- Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Sung-Bae Kim et al. LANCET ONCOLOGY
- Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China
- (2017) Yuxin Xie et al. MEDICINE
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
- (2017) Norikazu Masuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary Hormonal Contraception and the Risk of Breast Cancer
- (2017) Lina S. Mørch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
- (2017) Maria Vittoria Dieci et al. SEMINARS IN CANCER BIOLOGY
- Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial
- (2017) Akiko Hanai et al. JNCI-Journal of the National Cancer Institute
- Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
- (2017) Fergus J. Couch et al. JAMA Oncology
- Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer
- (2017) Eric Hahnen et al. JAMA Oncology
- Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
- (2017) Houssami Nehmat et al. Cancer Biology & Medicine
- New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes
- (2017) Oreste Claudio Buonomo et al. PLoS One
- Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2016) Albert L. Siu et al. ANNALS OF INTERNAL MEDICINE
- Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force
- (2016) Joy Melnikow et al. ANNALS OF INTERNAL MEDICINE
- Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation
- (2016) Heidi D. Nelson et al. ANNALS OF INTERNAL MEDICINE
- Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
- (2016) Heidi D. Nelson et al. ANNALS OF INTERNAL MEDICINE
- Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
- (2016) J. R. Mackey et al. ANNALS OF ONCOLOGY
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
- (2016) S. Paluch-Shimon et al. ANNALS OF ONCOLOGY
- Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
- (2016) Armando E. Giuliano et al. ANNALS OF SURGERY
- Breast Conservation Therapy Versus Mastectomy: Shared Decision-Making Strategies and Overcoming Decisional Conflicts in Your Patients
- (2016) Julie A. Margenthaler et al. ANNALS OF SURGICAL ONCOLOGY
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
- (2016) Abram Recht et al. ANNALS OF SURGICAL ONCOLOGY
- Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO “No Ink on Tumor” Guidelines
- (2016) Amanda M. Schulman et al. ANNALS OF SURGICAL ONCOLOGY
- DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
- (2016) Y. Ogitani et al. CLINICAL CANCER RESEARCH
- Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
- (2016) Jacques Bernier CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- Survival of de novo stage IV breast cancer patients over three decades
- (2016) Dieter Hölzel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ
- (2016) Monica Morrow et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
- (2016) Carolyn D. Runowicz et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Characterization of Primary Invasive Lobular Breast Cancer
- (2016) Christine Desmedt et al. JOURNAL OF CLINICAL ONCOLOGY
- DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
- (2016) Lise Bech Jellesmark Thorsen et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
- (2016) S. Avril et al. JOURNAL OF NUCLEAR MEDICINE
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
- (2016) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
- (2016) Luca Gianni et al. LANCET ONCOLOGY
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
- (2016) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1
- (2016) Birgitte V. Offersen et al. RADIOTHERAPY AND ONCOLOGY
- Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer
- (2016) Erin F. Cobain et al. SEMINARS IN ONCOLOGY
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Should breathing adapted radiotherapy also be applied for right-sided breast irradiation?
- (2015) Marion Essers et al. ACTA ONCOLOGICA
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer
- (2015) A. Chung et al. ANNALS OF SURGICAL ONCOLOGY
- Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
- (2015) Michael L. Marinovich et al. BMC CANCER
- Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response
- (2015) Christoph I. Lee et al. BREAST
- Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy
- (2015) Jose Vila et al. BREAST
- Clinical implications of molecular heterogeneity in triple negative breast cancer
- (2015) Brian D. Lehmann et al. BREAST
- Advancing breast cancer survivorship among African-American women
- (2015) Steven S. Coughlin et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan
- (2015) Mika Miyashita et al. CANCER NURSING
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Liquid biopsy
- (2015) Isabelle Gingras et al. CURRENT OPINION IN ONCOLOGY
- Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration
- (2015) F. Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Breast Cancer Screening for Women at Average Risk
- (2015) Kevin C. Oeffinger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Magnetic Resonance Imaging Improves Breast Screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-Analysis
- (2015) Xuan-Anh Phi et al. JOURNAL OF CLINICAL ONCOLOGY
- Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial
- (2015) Jun J. Mao et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic landscape of adenoid cystic carcinoma of the breast
- (2015) Luciano G Martelotto et al. JOURNAL OF PATHOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
- (2015) Lucia Del Mastro et al. LANCET
- Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
- (2015) Michael Gnant et al. LANCET
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
- (2015) LANCET
- Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
- (2015) Claudia Allemani et al. LANCET
- Removing the primary tumour in metastatic breast cancer
- (2015) David Cameron LANCET ONCOLOGY
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
- (2015) Rajendra Badwe et al. LANCET ONCOLOGY
- Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
- (2015) Harry Bartelink et al. LANCET ONCOLOGY
- The debate over post-mastectomy radiotherapy should continue
- (2015) Caspian Oliai et al. Nature Reviews Clinical Oncology
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
- (2015) Tari A. King et al. Nature Reviews Clinical Oncology
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
- (2015) Sara M. Tolaney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast-Cancer Screening — Viewpoint of the IARC Working Group
- (2015) Béatrice Lauby-Secretan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regional Nodal Irradiation in Early-Stage Breast Cancer
- (2015) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
- (2015) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
- (2015) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
- (2015) Philip M. Poortmans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
- (2015) M. C. U. Cheang et al. ONCOLOGIST
- Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
- (2015) O. Humbert et al. ONCOLOGIST
- Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective
- (2015) Elisa V Bandera et al. Advances in Nutrition
- Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
- (2015) J. L. Carter et al. BMJ-British Medical Journal
- Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
- (2015) J. L. Carter et al. BMJ-British Medical Journal
- Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State
- (2015) Betsy A. Kohler et al. JNCI-Journal of the National Cancer Institute
- EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review
- (2015) Jasmine Nguyen et al. Journal of Comparative Effectiveness Research
- Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
- (2014) M. Gnant et al. ANNALS OF ONCOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis
- (2014) Nehmat Houssami et al. ANNALS OF SURGICAL ONCOLOGY
- A Closer Look at Unmet Needs at the End of Primary Treatment for Breast Cancer: A Longitudinal Pilot Study
- (2014) Jessica L. Burris et al. BEHAVIORAL MEDICINE
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
- (2014) M Pennant et al. HEALTH TECHNOLOGY ASSESSMENT
- Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
- (2014) Meena S. Moran et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Sharon H. Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Postmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debate
- (2014) Philip Poortmans LANCET
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
- (2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group) LANCET
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
- (2014) Olivia Pagani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient-Reported Outcomes Measurement Information System (PROMIS): Efficient, standardized tools to measure self-reported health and quality of life
- (2014) Margaret Bevans et al. NURSING OUTLOOK
- Volumetric modulated arc therapy and breath-hold in image-guided locoregional left-sided breast irradiation
- (2014) Sarah O.S. Osman et al. RADIOTHERAPY AND ONCOLOGY
- Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: Evaluation of the National Surgical Quality Improvement Program data
- (2014) Judy C. Boughey et al. SURGERY
- First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients
- (2013) D. W. Miles et al. ANNALS OF ONCOLOGY
- Aromatase inhibitor-induced arthralgia: a review
- (2013) P. Niravath ANNALS OF ONCOLOGY
- A Systematic Review of Oncoplastic Breast-Conserving Surgery
- (2013) Max H. Haloua et al. ANNALS OF SURGERY
- Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement
- (2013) Patricia A. Ganz et al. BREAST
- Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998–2002
- (2013) Katharine Yao et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008–2012
- (2013) N. Thavarajah et al. Current Oncology
- Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial
- (2013) R.W. Blamey et al. EUROPEAN JOURNAL OF CANCER
- A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
- (2013) Gaetano Aurilio et al. EUROPEAN JOURNAL OF CANCER
- Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005–2009
- (2013) Andreas Stang et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
- (2013) Ellen M. Lavoie Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Exposures to Synthetic Estrogens at Different Times During the Life, and Their Effect on Breast Cancer Risk
- (2013) Leena Hilakivi-Clarke et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Supportive Cryotherapy: A Review From Head to Toe
- (2013) Kunal C. Kadakia et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Meta-Analysis of Magnetic Resonance Imaging in Detecting Residual Breast Cancer After Neoadjuvant Therapy
- (2013) Michael L. Marinovich et al. JNCI-Journal of the National Cancer Institute
- 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
- (2013) Aron Goldhirsch et al. LANCET
- Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
- (2013) Jayant S Vaidya et al. LANCET
- Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
- (2013) Umberto Veronesi et al. LANCET ONCOLOGY
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
- (2013) Joanne S Haviland et al. LANCET ONCOLOGY
- 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
- (2013) Xavier Pivot et al. LANCET ONCOLOGY
- Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
- (2013) Thorsten Kuehn et al. LANCET ONCOLOGY
- Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial
- (2013) Edward Chow et al. LANCET ONCOLOGY
- Surgical Management of the Breast
- (2013) Sarah A. McLaughlin SURGICAL CLINICS OF NORTH AMERICA
- WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
- (2013) Daniel Hofmann et al. Trials
- Early prediction of pathologic response to neoadjuvant therapy in breast cancer: Systematic review of the accuracy of MRI
- (2012) M.L. Marinovich et al. BREAST
- Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
- (2012) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole-genome analysis informs breast cancer response to aromatase inhibition
- (2012) Matthew J. Ellis et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Surgical Margins in Lumpectomy for Breast Cancer — Bigger Is Not Better
- (2012) Monica Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- An “elite hacker”
- (2012) Aaron Boudreau et al. Cell Adhesion & Migration
- BRCA in breast cancer: ESMO Clinical Practice Guidelines
- (2011) J. Balmana et al. ANNALS OF ONCOLOGY
- Preoperative Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer
- (2011) Nehmat Houssami et al. ANNALS OF SURGERY
- Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression
- (2011) Pooja Vasudev et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Breast cancer in a multi-ethnic Asian setting: Results from the Singapore–Malaysia hospital-based breast cancer registry
- (2011) Nirmala Bhoo Pathy et al. BREAST
- Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health Study
- (2011) Rehana L. Ahmed et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- The prognostic significance of lymphovascular invasion in invasive breast carcinoma
- (2011) Emad A. Rakha et al. CANCER
- Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk
- (2011) Wendy Y. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
- (2011) Armando E. Giuliano JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer
- (2011) Patricia A. Ganz et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- MRI for breast cancer screening, diagnosis, and treatment
- (2011) Monica Morrow et al. LANCET
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Local treatment of metastatic cancer—killing the seed or disturbing the soil?
- (2011) Scott C. Morgan et al. Nature Reviews Clinical Oncology
- Leukocyte composition of human breast cancer
- (2011) B. Ruffell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Quality Indicators for Breast Cancer: Revisiting Historical Evidence in the Context of Technology Changes
- (2011) Philip Poortmans et al. SEMINARS IN RADIATION ONCOLOGY
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
- (2010) Krishna B. Clough et al. ANNALS OF SURGICAL ONCOLOGY
- Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
- (2010) Francesco Sardanelli et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer precursors revisited: molecular features and progression pathways
- (2010) Maria A Lopez-Garcia et al. HISTOPATHOLOGY
- Effect of Endocrine Therapies on Bone in Breast Cancer Patients
- (2010) R. J. Santen JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
- (2010) Larissa A. Korde et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- The molecular pathology of breast cancer progression
- (2010) Alessandro Bombonati et al. JOURNAL OF PATHOLOGY
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
- (2010) David N Krag et al. LANCET ONCOLOGY
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
- (2010) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
- (2010) Csaba Polgár et al. RADIOTHERAPY AND ONCOLOGY
- Is Breast Cancer the Same Disease in Asian and Western Countries?
- (2010) Stanley P. L. Leong et al. WORLD JOURNAL OF SURGERY
- Randomized Trial Comparing Locoregional Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at the Presentation (Protocol MF07-01): A Study of Turkish Federation of the National Societies for Breast Diseases
- (2009) Atilla Soran et al. Breast Journal
- Standardized synoptic cancer pathology reporting: A population-based approach
- (2009) John R. Srigley et al. JOURNAL OF SURGICAL ONCOLOGY
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items
- (2009) Ron D. Hays et al. QUALITY OF LIFE RESEARCH
- Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample
- (2009) Dennis A. Revicki et al. QUALITY OF LIFE RESEARCH
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors
- (2008) Gary Elkins et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now